Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

2.

A strategy to improve the efficacy of vaccination against tuberculosis and leprosy.

Bretscher PA.

Immunol Today. 1992 Sep;13(9):342-5. Review.

PMID:
1466750
3.

[Eradication of leprosy and public health. Vaccination and multidrug therapy].

Janaszek W.

Przegl Epidemiol. 2002;56(4):577-86. Review. Polish.

PMID:
12666583
4.

ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.

Velema JP, Ogbeiwi OI.

Lepr Rev. 2007 Jun;78(2):88-101. Review.

PMID:
17824479
5.

Immunotherapy and immunoprophylaxis of leprosy.

Convit J, Aranzazu N, Zúñiga M, Ulrich M, Pinardi ME, Castellazzi Z, Alvarado J.

Lepr Rev. 1983 Jun;Spec No:47-60. Review. No abstract available.

PMID:
6350772
6.

Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.

Gormus BJ, Meyers WM.

Expert Rev Vaccines. 2003 Dec;2(6):791-804. Review.

PMID:
14711362
7.

[Development of antileprosy vaccines].

Kalianina OV, Iushchenko AA.

Zh Mikrobiol Epidemiol Immunobiol. 2005 Mar-Apr;(2):93-100. Review. Russian.

PMID:
15881952
8.

New strategies for leprosy and tuberculosis and for development of bacillus Calmette-Guérin into a multivaccine vehicle.

Bloom BR, Jacobs WR Jr.

Ann N Y Acad Sci. 1989;569:155-73. Review. No abstract available.

PMID:
2516995
9.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
10.

Leprosy and tuberculosis vaccine design.

Kaufmann SH.

Trop Med Parasitol. 1989 Sep;40(3):251-7. Review.

PMID:
2482532
11.

Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis.

Richardus JH, Oskam L.

Clin Dermatol. 2015 Jan-Feb;33(1):19-25. doi: 10.1016/j.clindermatol.2014.07.009. Review.

PMID:
25432807
12.

Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials.

Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, Rodrigues LC, Smith PG, Lipman M, Whiting PF, Sterne JA.

Clin Infect Dis. 2014 Feb;58(4):470-80. doi: 10.1093/cid/cit790. Epub 2013 Dec 13. Review.

13.

Modern vaccines. Mycobacterial diseases.

Fine PE, Rodrigues LC.

Lancet. 1990 Apr 28;335(8696):1016-20. Review. No abstract available.

PMID:
1970071
14.

[A systematic review on the protective efficacy of BCG against children tuberculosis meningitis and millet tuberculosis].

Xiong CH, Liang XF, Wang HQ.

Zhongguo Yi Miao He Mian Yi. 2009 Aug;15(4):358-62. Review. Chinese.

PMID:
20077739
15.

Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis.

Roy A, Eisenhut M, Harris RJ, Rodrigues LC, Sridhar S, Habermann S, Snell L, Mangtani P, Adetifa I, Lalvani A, Abubakar I.

BMJ. 2014 Aug 5;349:g4643. doi: 10.1136/bmj.g4643. Review.

16.

Is BCG vaccination against tuberculosis still indicated?

Vanderschueren S, Peetermans W, Bobbaers H.

Acta Clin Belg. 1994;49(3-4):138-47. Review.

PMID:
7941924
17.

[Leprosy is definitely not a disease of the past].

Mahé A.

Med Sci (Paris). 2015 Aug-Sep;31(8-9):764-9. doi: 10.1051/medsci/20153108015. Epub 2015 Sep 4. Review. French.

18.

[Human mycobacterial infections: impact of host genetic factors].

Plancoulaine S, Alcaïs A, Abel L, Casanova JL.

Rev Med Liege. 2002 Mar;57(3):165-70. Review. French.

PMID:
12014265
19.

Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy.

Duthie MS, Balagon MF.

Risk Manag Healthc Policy. 2016 Apr 27;9:43-53. doi: 10.2147/RMHP.S76058. eCollection 2016. Review.

20.

Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy.

Mieras L, Anthony R, van Brakel W, Bratschi MW, van den Broek J, Cambau E, Cavaliero A, Kasang C, Perera G, Reichman L, Richardus JH, Saunderson P, Steinmann P, Yew WW.

Infect Dis Poverty. 2016 Jun 8;5(1):46. doi: 10.1186/s40249-016-0140-y. Review.

Items per page

Supplemental Content

Write to the Help Desk